Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biomarin Pharmaceuticals (NQ: BMRN ) 90.02 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,262,422 Open 90.00 Bid (Size) 80.00 (1) Ask (Size) 91.00 (1) Prev. Close 90.02 Today's Range 89.37 - 90.79 52wk Range 73.67 - 99.56 Shares Outstanding 183,352,255 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 24 August 24, 2024 What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Aug. 19-23, 2024. Via Talk Markets (BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest August 21, 2024 Via Benzinga Performance YTD -8.19% -8.19% 1 Month +5.18% +5.18% 3 Month +20.95% +20.95% 6 Month -0.09% -0.09% 1 Year -3.87% -3.87% More News Read More Beyond The Numbers: 11 Analysts Discuss Biomarin Pharmaceutical Stock August 20, 2024 Via Benzinga Palo Alto Networks To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday August 20, 2024 Via Benzinga NASDAQ:BMRN is not too expensive for the growth it is showing. August 14, 2024 Via Chartmill Investors seeking growth at a reasonable cost should explore NASDAQ:BMRN. July 24, 2024 Via Chartmill $1000 Invested In This Stock 20 Years Ago Would Be Worth $16,000 Today July 16, 2024 Via Benzinga Peering Into Biomarin Pharmaceutical's Recent Short Interest July 04, 2024 Via Benzinga $1000 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today August 07, 2024 Via Benzinga Rare Disease-Focused BioMarin Narrows Sales Focus, Cuts Cost For Hemophilia A Gene Therapy; Lifts Annual Guidance August 06, 2024 Via Benzinga Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday August 06, 2024 Via Benzinga Biomarin Pharmaceutical Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Results August 06, 2024 Via Benzinga Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical June 27, 2024 Via Benzinga Looking Into Biomarin Pharmaceutical's Recent Short Interest May 28, 2024 Via Benzinga NASDAQ:BMRN is not too expensive for the growth it is showing. May 21, 2024 Via Chartmill BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Beats Revenue for Q2 2024 August 05, 2024 Via InvestorPlace A Glimpse Into The Expert Outlook On Biomarin Pharmaceutical Through 10 Analysts July 22, 2024 Via Benzinga $100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today July 18, 2024 Via Benzinga Investors should take note of NASDAQ:BMRN, a growth stock that remains attractively priced. July 02, 2024 Via Chartmill For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering. June 11, 2024 Via Chartmill CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump June 07, 2024 Via Investor's Business Daily Topics Stocks Exposures US Equities June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge June 05, 2024 Via InvestorPlace 10 Health Care Stocks Whale Activity In Today's Session June 04, 2024 Via Benzinga BridgeBio Stock Makes A Bullish Move On Dwarfism Treatment Results June 04, 2024 Via Investor's Business Daily Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024) May 19, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.